Health care stocks advanced late Friday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both adding 0.9%.
The iShares Biotechnology ETF (IBB) also climbed 0.9%.
In corporate news, IceCure Medical (ICCM) shares rose 4.9% after the company received an intention to grant notice from the European Patent Office for its cryoablation technology.
Bionano Genomics (BNGO) shares jumped 20%. The company announced a registered direct offering to certain institutional investors for almost 39.7 million shares and related warrants at $0.252 apiece to raise $10 million.
Cyclacel Pharmaceuticals (CYCC) shares surged 26% after investor David Lazar agreed to buy $3.1 million in the company's preferred stock and was named interim chief executive.
Neumora Therapeutics' (NMRA) readout of its first phase 3 trial of navacaprant in major depressive disorder was a "significant miss," though the company has two more chances, Mizuho Securities said in a report. Neumora shares rose 13%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。